| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Smith Stan is a Director at MAIA Biotechnology, Inc.. Recent SEC Form 4 filings include 6 buys and 0 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2022 | MAIA Maia Biotechnology, Inc. | Director | Buy | 1,712 | $3.40 | $5,825.99 | +0.2% | -8.4% | -67.2% | |
| Dec 21, 2022 | MAIA Maia Biotechnology, Inc. | Director | Buy | 4,447 | $3.52 | $15,658.01 | +0.4% | -7.6% | -68.9% | |
| Sep 19, 2022 | MAIA Maia Biotechnology, Inc. | Director | Buy | 2,700 | $3.69 | $9,958.68 | +0.2% | -8.4% | -56.2% | |
| Aug 1, 2022 | MAIA Maia Biotechnology, Inc. | Director | Buy | 200,000 | $5.00 | $1,000,000.00 | +67.5% | -53.2% | -71.9% |